Table 2.

Clinical rationale for SCT in CR1 (n = 45)

Clinical rationaleN of patients (%)
Age >60 y 17 (38) 
FLT3-ITD 25 (56) 
Abnormal cytogenetics 3 (7) 
Unfavorable molecular profile 6 (13) 
Extramedullary disease 3 (7) 
Clinical rationaleN of patients (%)
Age >60 y 17 (38) 
FLT3-ITD 25 (56) 
Abnormal cytogenetics 3 (7) 
Unfavorable molecular profile 6 (13) 
Extramedullary disease 3 (7) 

Some cases had multiple clinical rationales.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal